We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

75 hedge funds and large institutions have $6.3M invested in Ampio Pharmaceuticals Inc. in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

756% more call options, than puts

Call options by funds: $137K | Put options by funds: $16K

45% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 11

7% less funds holding

Funds holding: 81 → 75 (-6)

21% less capital invested

Capital invested by funds: $7.96M → $6.3M (-$1.66M)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
75
Holders Change
-6
Holders Change %
-7.41%
% of All Funds
1.64%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
16
Reduced
11
Closed
15
Calls
$137K
Puts
$16K
Net Calls
+$121K
Net Calls Change
-$84K

Top Buyers

Rank Fund Capital Flow
1
PCMC
Private Capital Management (Colorado)
Colorado
+$290K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$290K
3
WWM
Western Wealth Management
Colorado
+$233K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$176K
5
Renaissance Technologies
Renaissance Technologies
New York
+$77.8K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$2.04M
2
Millennium Management
Millennium Management
New York
-$776K
3
Northern Trust
Northern Trust
Illinois
-$392K
4
Bank of America
Bank of America
North Carolina
-$234K
5
Goldman Sachs
Goldman Sachs
New York
-$191K
Name Holding Trade Value Shares
Change 		Change in
Stake
SGCA
26
Steel Grove Capital Advisors
Tennessee
$28K – – –
RJFSA
27
Raymond James Financial Services Advisors
Florida
$27K +$2.27K +17 +10%
TCM
28
Traynor Capital Management
Pennsylvania
$27K +$2.67K +20 +12%
State Street
29
State Street
Massachusetts
$23K – – –
UCFA
30
United Capital Financial Advisors
Texas
$23K +$5.46K +41 +36%
UBS Group
31
UBS Group
Switzerland
$22K +$19.3K +145 +4,833%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$21K – – –
GWM
33
Geneos Wealth Management
Colorado
$21K +$15.2K +114 +345%
CPIG
34
Chicago Partners Investment Group
Illinois
$20K +$4.53K +34 +30%
TFS
35
TrustCore Financial Services
Tennessee
$19K +$5.86K +44 +54%
LP
36
LMR Partners
United Kingdom
$16K – – –
VF
37
Virtu Financial
New York
$15K -$799 -6 -6%
HAG
38
HighPoint Advisor Group
Illinois
$15K -$666 -5 -3%
CCB
39
Cutter & Co Brokerage
Missouri
$13K – – –
JWA
40
JFS Wealth Advisors
Pennsylvania
$13K – – –
Citigroup
41
Citigroup
New York
$12K -$6.26K -47 -38%
Morgan Stanley
42
Morgan Stanley
New York
$11K -$57.2K -429 -86%
Victory Capital Management
43
Victory Capital Management
Texas
$11K +$10.1K +76 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$10K – – –
Wolverine Trading
45
Wolverine Trading
Illinois
$10K +$2.27K +17 +35%
Wells Fargo
46
Wells Fargo
California
$8K -$2.67K -20 -27%
Brown Advisory
47
Brown Advisory
Maryland
$8K – – –
IWM
48
IHT Wealth Management
Illinois
$8K – – –
JWM
49
Janiczek Wealth Management
Colorado
$8K – – –
Commonwealth Equity Services
50
Commonwealth Equity Services
Massachusetts
$7K – – –
1
2
3 4

AMPE Hedge Fund Activity: Q3 2019 in Review

75 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q3 2019, worth a combined $6.3M — down 21% from $7.96M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of AMPE and 9 opened new positions — a net loss of 6 holders — while 11 trimmed existing stakes and 16 added.

The largest buyer was Private Capital Management (Colorado), opening a new position worth an estimated $290K. The largest seller was Sabby Management, exiting entirely with an estimated $2.04M sold.

  • 75 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q3 2019, down from 81 in Q2 2019.
  • Funds reported $6.3M of Ampio Pharmaceuticals Inc. stock for Q3 2019, down 21% quarter-over-quarter.
  • 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q3 2019 and 15 closed out, a net change of -6 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q3 2019 was Private Capital Management (Colorado), an estimated $290K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q3 2019 was Sabby Management, an estimated $2.04M sold.

Based on aggregated 13F filings for Q3 2019.